医学
乙型肝炎病毒
临床试验
核苷类似物
乙型肝炎
病毒
中医药
免疫学
抗病毒治疗
抗原
药品
病毒学
内科学
慢性肝炎
恩替卡韦
临床研究
抗病毒药物
抗病毒治疗
公共卫生
抗药性
HBeAg
不利影响
核苷
传统医学
临床疗效
肝炎
替代医学
干扰素
临床实习
病毒性疾病
作者
Xue Feng,Nannan Li,Guijian Liu,Cheng An,Chao Liu
标识
DOI:10.4254/wjh.v17.i9.107806
摘要
Hepatitis B virus (HBV) is a serious global public health concern. Although nucleoside drugs and interferons can significantly inhibit HBV replication, issues such as drug resistance and low clinical cure rates remain. Traditional Chinese medicine (TCM) is widely used in the treatment of chronic hepatitis B (CHB) in China, with anti-inflammatory, anti-fibrotic, and liver-protective effects; however, reports on its antiviral effects are still inconsistent. We retrieved multicenter clinical studies and meta-analyses of TCM treatment for CHB over the past two decades. The results revealed that TCM has a certain anti-HBV effect, and when combined with antiviral drugs, it can significantly improve antiviral efficacy. It was demonstrated that TCM most effectively promotes serum HBV e antigen conversion to negative, followed by the ability to reduce HBV DNA levels, facilitating HBV surface antigen loss, and improving the treatment of CHB.
科研通智能强力驱动
Strongly Powered by AbleSci AI